Literature DB >> 4025385

Noonan syndrome: the changing phenotype.

J E Allanson, J G Hall, H E Hughes, M Preus, R D Witt.   

Abstract

Among the multiple congenital anomalies (MCA) syndromes, the Noonan syndrome (NS) is a cardiofacial syndrome in which affected individuals may be short and mildly mentally retarded. Autosomal dominant inheritance of Noonan syndrome with variable expressivity has been documented in many families. Genetic heterogeneity has been postulated in Noonan syndrome because of the wide phenotypic variability, the relatively high incidence, and the occasional recurrence in sibs with apparently normal parents. Clinical variability is usual in autosomal dominant disorders, and mildly affected individuals may be difficult to recognize as gene carriers. Thus, a family with two or more affected children may simulate autosomal recessive inheritance. We have studied serial and family photographs of NS individuals in order to assess the likelihood of gene carriers' being missed in genetic studies. We have confirmed wide clinical variability within families, and more importantly, we have documented marked change of phenotype with age from the newborn period, infancy, childhood, and adolescence to adulthood. Manifestations in adults may be subtle and some without a known heart defect or other medically significant problems may have been considered normal in the past. Our study, while not ruling out causal heterogeneity, suggests that the change of phenotype with age may have been falsely perceived as clinical heterogeneity. A particular and subtle phenotype must be searched for in parents of affected children.

Entities:  

Mesh:

Year:  1985        PMID: 4025385     DOI: 10.1002/ajmg.1320210313

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  46 in total

1.  De Lange syndrome: subjective and objective comparison of the classical and mild phenotypes.

Authors:  J E Allanson; R C Hennekam; M Ireland
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

2.  Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus.

Authors:  M Sharland; R Taylor; M A Patton; S Jeffery
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

3.  A clinical study of Noonan syndrome.

Authors:  M Sharland; M Burch; W M McKenna; M A Paton
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

4.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

5.  Discriminating power of localized three-dimensional facial morphology.

Authors:  Peter Hammond; Tim J Hutton; Judith E Allanson; Bernard Buxton; Linda E Campbell; Jill Clayton-Smith; Dian Donnai; Annette Karmiloff-Smith; Kay Metcalfe; Kieran C Murphy; Michael Patton; Barbara Pober; Katrina Prescott; Pete Scambler; Adam Shaw; Ann C M Smith; Angela F Stevens; I Karen Temple; Raoul Hennekam; May Tassabehji
Journal:  Am J Hum Genet       Date:  2005-10-26       Impact factor: 11.025

6.  PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome.

Authors:  Jung Min Ko; Jae-Min Kim; Gu-Hwan Kim; Han-Wook Yoo
Journal:  J Hum Genet       Date:  2008-11-20       Impact factor: 3.172

Review 7.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

8.  1995 ASHG presidential address. The challenges and opportunities of times of change.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

9.  Behavioural aspects and psychiatric findings in Noonan's syndrome.

Authors:  A Wood; A Massarano; M Super; R Harrington
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

Review 10.  Ras/MAPK syndromes and childhood hemato-oncological diseases.

Authors:  Yoko Aoki; Yoichi Matsubara
Journal:  Int J Hematol       Date:  2012-12-19       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.